SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
19563346
Source:
http://linkedlifedata.com/resource/pubmed/id/19563346
Search
Subject
(
65
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0001779
,
umls-concept:C0003286
,
umls-concept:C0003299
,
umls-concept:C0060135
,
umls-concept:C0205210
,
umls-concept:C0242510
,
umls-concept:C0443252
,
umls-concept:C0449297
,
umls-concept:C0521115
,
umls-concept:C1274040
,
umls-concept:C1280500
,
umls-concept:C1524063
pubmed:issue
11
pubmed:dateCreated
2009-10-30
pubmed:abstractText
To determine the effects of long-term use of felbamate (FBM) on weight, complete blood count, liver function tests, and seizure control, and also to determine the effect of age on FBM clearance.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/P50-NS16308
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/2983306R
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anticonvulsants
,
http://linkedlifedata.com/resource/pubmed/chemical/Phenylcarbamates
,
http://linkedlifedata.com/resource/pubmed/chemical/Propylene Glycols
,
http://linkedlifedata.com/resource/pubmed/chemical/felbamate
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1528-1167
pubmed:author
pubmed-author:BeattieJeanne LJL
,
pubmed-author:LeppikIlo EIE
,
pubmed-author:RarickJohn OJO
,
pubmed-author:TranTeresa ATA
,
pubmed-author:VaherPaulP
,
pubmed-author:WalczakThaddeus STS
,
pubmed-author:WhiteJames RJR
pubmed:issnType
Electronic
pubmed:volume
50
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2390-6
pubmed:meshHeading
pubmed-meshheading:19563346-Adolescent
,
pubmed-meshheading:19563346-Adult
,
pubmed-meshheading:19563346-Age Factors
,
pubmed-meshheading:19563346-Aged
,
pubmed-meshheading:19563346-Anticonvulsants
,
pubmed-meshheading:19563346-Child
,
pubmed-meshheading:19563346-Dose-Response Relationship, Drug
,
pubmed-meshheading:19563346-Drug Therapy, Combination
,
pubmed-meshheading:19563346-Female
,
pubmed-meshheading:19563346-Humans
,
pubmed-meshheading:19563346-Long-Term Care
,
pubmed-meshheading:19563346-Male
,
pubmed-meshheading:19563346-Medical Records
,
pubmed-meshheading:19563346-Metabolic Clearance Rate
,
pubmed-meshheading:19563346-Middle Aged
,
pubmed-meshheading:19563346-Phenylcarbamates
,
pubmed-meshheading:19563346-Propylene Glycols
,
pubmed-meshheading:19563346-Prospective Studies
,
pubmed-meshheading:19563346-Seizures
,
pubmed-meshheading:19563346-Treatment Outcome
pubmed:year
2009
pubmed:articleTitle
Long-term use of felbamate: clinical outcomes and effect of age and concomitant antiepileptic drug use on its clearance.
pubmed:affiliation
MINCEP Epilepsy Care, Minneapolis, Minnesota 55416, USA. jrwhitemincep@msn.com
pubmed:publicationType
Journal Article
,
Comparative Study
,
Research Support, N.I.H., Extramural